Cleared Traditional

K830280 - PHADEZYM B2 MICRO TEST 100 (FDA 510(k) Clearance)

K830280 · Pharmacia, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1983
Decision
58d
Days
-
Risk

K830280 is an FDA 510(k) clearance for the PHADEZYM B2 MICRO TEST 100.

Submitted by Pharmacia, Inc. (Mchenry, US). The FDA issued a Cleared decision on March 25, 1983 after a review of 58 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Pharmacia, Inc. devices

Submission Details

510(k) Number K830280 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 26, 1983
Decision Date March 25, 1983
Days to Decision 58 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
46d faster than avg
Panel avg: 104d · This submission: 58d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code -
Device Class -